- Home
- RCUS vs NVRI Comparison
RCUS vs NVRI Comparison
Compare RCUS & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- NVRI
- Stock Information
- Founded
- RCUS 2015
- NVRI 1853
- Country
- RCUS United States
- NVRI United States
- Employees
- RCUS N/A
- NVRI N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- NVRI Diversified Commercial Services
- Sector
- RCUS Health Care
- NVRI Miscellaneous
- Exchange
- RCUS Nasdaq
- NVRI Nasdaq
- Market Cap
- RCUS 1.2B
- NVRI 996.0M
- IPO Year
- RCUS 2018
- NVRI N/A
- Fundamental
- Price
- RCUS $17.35
- NVRI $13.40
- Analyst Decision
- RCUS Buy
- NVRI Hold
- Analyst Count
- RCUS 8
- NVRI 1
- Target Price
- RCUS $26.50
- NVRI $10.00
- AVG Volume (30 Days)
- RCUS 1.2M
- NVRI 888.5K
- Earning Date
- RCUS 11-05-2025
- NVRI 11-10-2025
- Dividend Yield
- RCUS N/A
- NVRI N/A
- EPS Growth
- RCUS N/A
- NVRI N/A
- EPS
- RCUS N/A
- NVRI N/A
- Revenue
- RCUS $262,000,000.00
- NVRI $2,242,873,000.00
- Revenue This Year
- RCUS N/A
- NVRI N/A
- Revenue Next Year
- RCUS N/A
- NVRI $3.72
- P/E Ratio
- RCUS N/A
- NVRI N/A
- Revenue Growth
- RCUS 6.07
- NVRI N/A
- 52 Week Low
- RCUS $6.50
- NVRI $4.72
- 52 Week High
- RCUS $18.98
- NVRI $13.53
- Technical
- Relative Strength Index (RSI)
- RCUS 64.78
- NVRI 71.98
- Support Level
- RCUS $16.41
- NVRI $12.54
- Resistance Level
- RCUS $18.42
- NVRI $13.10
- Average True Range (ATR)
- RCUS 1.17
- NVRI 0.45
- MACD
- RCUS 0.04
- NVRI 0.06
- Stochastic Oscillator
- RCUS 75.30
- NVRI 91.75
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.